May 13, 2025
Mr. Spota brings to Eleva profound expertise in complementary business areas including strategic finance, investor relations, business development and international capital markets transactions.
April 25, 2025
Eleva confirms dry AMD as second indication for proprietary Factor H (CPV-104) program
Next Page